[New opportunities for inhaled therapy for inflammatory diseases of the respiratory system].
The paper considers current approaches to mucoregulatory therapy for various inflammatory diseases of the respiratory system.
It gives the advantages and disadvantages of common drugs used in their treatment.  Emphasis is laid on the use of inhaled hypertonic saline of NaCl in combination with hyaluronic acid (Hyaneb).
Clinical examples of its use in chronic obstructive pulmonary disease, acute and chronic bronchitis, and severe asthma are considered.
